Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 324

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 324
---
View after the close of the IPO is consistent with the scope of the BCMA. As is customary, I -Bankersand Dawson James also introduced NorthView to prospective target companies post -IPOand aided the Company in its evaluation of prospective target companies. Profusa’s officers and directors do not hold any material interests that consist of any interest in, or affiliation with, the Sponsor or NorthView. Potential Actions to Secure Requisite Stockholder Approvals In connection with the stockholder vote to approve the Business Combination, the Sponsor and NorthView’s directors, officers, advisors or their affiliates may privately negotiate transactions to purchase shares of NorthView Common Stock from stockholders who would have otherwise elected to have their shares redeemed in conjunction with the Business Combination for a per -sharepro rata portion of the Trust Account. None of the Sponsor or NorthView’s directors, officers, advisors or their affiliates will make any such purchases when they are in possession of any material non -publicinformation not disclosed to the seller. Such a purchase of shares may include a contractual acknowledgement that such stockholder, although still the record holder of the shares of NorthView Common Stock is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that the Sponsor or NorthView’s directors, officers, advisors or their affiliates purchase shares in privately negotiated transactions from NorthView Holders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their shares. Any such transaction would be separately negotiated at the time of the transaction. The consideration for any such transaction would consist of cash and/or NorthView Common Stock owned by the Sponsor and/or NorthView’s directors, officers, advisors, or their affiliates. While the exact nature of any such incentives has not been determined as of the date of this proxy statement/prospectus, they might include, without limitation, arrangements to protect such investors or holders against potential loss in value of their shares, including the granting of put options and, with Profusa’s consent, the transfer to such investors or holders of shares owned by the Sponsors for nominal value. In such transactions, the purchase price for the NorthView Common Stock will not exceed the per -shareredemption amount available to redeeming shareholders. In addition, the purchasers described above will waive redemption rights, if any, with respect to the NorthView Common Stock they acquire in such transactions. The purpose of such share purchases would be to increase the likelihood of obtaining stockholder approval of the Business Combination or